The ROAM Research Study Therapy (LTOT) Version
The Respiratory Oxygen Adherence Monitor System for COPD With Long Term Oxygen Therapy
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- No age limits stated
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
The purpose of this research is to test a device being developed that can see how patients use oxygen therapy over a long period of time. This study will focus on developing a new display part called ROAM module which will be attached to your oxygen source. The display will provide easily-accessible information that can show how you interact with your supplies and the oxygen machine automatically without connecting the oxygen source to the internet or other devices.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: Post-Bronchodilator FEV1/FVC \<.80 * Race demographics of the recruitment area reflect the population of the Charlottesville Metropolitan Statistical Area (MSA). * Due to underrepresentation in local demographics, special effort (via targeted advertising) will be made to recruit Hispanic participants to better match national percentages. * Participants with medical history of COPD * Subjects has to have a prescription for oxygen use via nasal cannula or mask at home * At baseline of health with no hospitalization/exacerbation within the past 6 weeks * Use of Continuous oxygen at baseline Exclusion Criteria: Post -Bronchodilator FEV1 \< 25% * Intermittent oxygen use at home * Inability to understand simple instructions * No respiratory infections and exacerbation within 6 weeks of study
Study sites (1)
VA
- University of Virginia · Charlottesville, VA 22903Roselove Nunoo-Asare, MA · Study contact · 434-243-6074 · RNN3B@VIRGINIA.EDUYun M Shim, MD · Principal investigatorMore trials in Charlottesville